Results 51 to 60 of about 6,215,751 (161)

An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening. [PDF]

open access: yesACS Pharmacol Transl Sci, 2020
Kinarivala N   +8 more
europepmc   +2 more sources

Prospective pilot safety, feasibility study of an optic-to-audio device for children with CLN3 disease. [PDF]

open access: yesOrphanet J Rare Dis
Background Low-vision rehabilitative support for children with multiple-disability conditions is underexplored. We conduct a pilot study of an assistive device in children with CLN3 disease, a multisystemic pediatric blindness and neurodegenerative ...
Nguyen TT   +13 more
europepmc   +2 more sources

Gene correction of the CLN3 c.175G>A variant in patient‐derived induced pluripotent stem cells prevents pathological changes in retinal organoids

open access: yesMolecular Genetics & Genomic Medicine, 2021
Background Mutations in CLN3 cause Batten disease, however non‐syndromic CLN3 disease, characterized by retinal‐specific degeneration, has been also described.
Xiao Zhang   +10 more
doaj   +1 more source

CLN3, at the crossroads of endocytic trafficking

open access: yes, 2021
The CLN3 gene was identified over two decades ago, but the primary function of the CLN3 protein remains unknown. Recessive inheritance of loss of function mutations in CLN3 are responsible for juvenile neuronal ceroid lipofuscinosis (Batten disease, or ...
Lefrancois, Stephane   +4 more
core   +1 more source

A central role for TOR signalling in a yeast model for juvenile CLN3 disease [PDF]

open access: yes, 2015
Yeasts provide an excellent genetically tractable eukaryotic system for investigating the function of genes in their biological context, and are especially relevant for those conserved genes that cause disease.
Bond, ME   +14 more
core   +1 more source

Small Molecules that Rescue Multiple Phenotypic Aberrations in an iPSC-Derived Neuron Model of CLN3 Disease [PDF]

open access: yes, 2020
The neuronal ceroid lipofuscinoses (NCLs) commonly referred to as Batten disease are a family of rare lysosomal storage disorders (LSDs). The most common form of NCL occurs in children harboring a mutation in the CLN3 gene.
Ahmed, Morsy   +8 more
core   +1 more source

Membrane topology of CLN3, the protein underlying Batten disease [PDF]

open access: yesFEBS Letters, 2003
Juvenile neuronal ceroid lipofuscinosis, or Batten disease, is an autosomal recessive disorder characterized by progressive loss of motor and cognitive functions, loss of vision, progressively severe seizures, and death. The disease is associated with mutations in the gene CLN3, which encodes a novel 438 amino acid protein, the function of which is ...
Mao, Qinwen   +3 more
openaire   +2 more sources

A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease [PDF]

open access: yesScientific Reports, 2020
AbstractCLN3 Batten disease (CLN3 disease) is a pediatric lysosomal storage disorder that presents with progressive blindness, motor and cognitive decline, seizures, and premature death. CLN3 disease results from mutations in CLN3 with the most prevalent mutation, a 966 bp deletion spanning exons 7–8, affecting ~ 75% of patients.
Langin, Logan   +4 more
openaire   +2 more sources

The Lysosomal Clock: Are We Only as Old as Our Lysosomes? [PDF]

open access: yesTraffic
The lysosomal clock of aging. Aging is associated with lysosomal accumulation of glycerophosphodiesters (GPDs) and cystine, alongside remodeling of bis(monoacylglycero)phosphate (BMP). This conserved metabolic signature predicts chronological age, is attenuated by caloric restriction in peripheral tissues, and is prominent in brain microglia and ...
Vegas AD, Galli T.
europepmc   +2 more sources

Protocol for screening of small molecules in a CLN3 disease patient-specific iPSC-derived neuronal progenitor cell model. [PDF]

open access: yesSTAR Protoc
Summary: Although rare, CLN3 disease is the most common neurodegenerative disorder of childhood. Here, we present a protocol for screening small molecules in a CLN3 disease patient-specific induced pluripotent stem cell (iPSC)-derived neuronal progenitor
Venkatesan R, Trippier PC.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy